Conversion of the Bifunctional 8-oxoguanine/β-δ AP DNA Repair Activities of Drosophila Ribosomal Protein S3 into the Human S3 Monofunctional β- elimination Catalyst Through a Single Amino Acid Change by Hegde, Vijay et al.
1Conversion of the Bifunctional 8-oxoguanine/β-δ AP
DNA Repair Activities of Drosophila Ribosomal Protein
S3 into the Human S3 Monofunctional β- elimination
Catalyst Through a Single Amino Acid Change*
Vijay Hegde, Mark R. Kelley‡§, Yi Xu‡, Saira Mian¶, and Walter A. Deutsch||
From the Pennington Biomedical Research Center, Louisiana State University,
Baton Rouge, LA 70808, ‡ Department of Pediatrics, Herman B Wells Center for
Pediatric Research, Indiana University School of Medicine, Indianapolis, IN
46202, § Department of Biochemistry and Molecular Biology, Indianapolis, IN
46202, and ¶ Department of Cell and Molecular Biology, Life Sciences Division,
Lawrence Berkeley National Laboratory, Berkeley, CA  94720
* This work was supported by the National Institutes of Health (M.R.K. and W. A.
D.) and by the Director, Office of Energy Research, Office of Health and
Environmental Research, Division of the US Department of Energy (S. M.)
|| To whom correspondence should be addressed: Pennington Biomedical
Research Center, 6400 Perkins, Baton Rouge, LA 70808.E-mail:
deutscwa@pbrc.edu
Author's version. Final version published as:
Hegde V, Kelley MR, Xu Y, Mian IS, Deutsch WA. Conversion of the bifunctional 8-oxoguanine/beta-delta apurinic/
apyrimidinic DNA repair activities of Drosophila ribosomal protein S3 into the human S3 monofunctional beta-
elimination catalyst through a single amino acid change. J Biol Chem. 2001 Jul 20;276(29):27591-6. Available from: 
http://dx.doi.org/10.1074/jbc.M101213200
2Summary
The Drosophila S3 ribosomal protein has important roles in both protein translation and
DNA repair. In regards to the latter activity, it has been shown that S3 contains vigorous
N-glycosylase activity for the removal of 8-oxoguanine residues in DNA that leaves a
baseless site in its place. Drosophila S3 also possesses an apurinic/apyrimidinic (AP)
lyase activity in which the enzyme catalyzes a β-elimination reaction that cleaves
phosphodiester bonds 3’ and adjacent to an AP lesion in DNA. In certain situations, this
is followed by a δ-elimination reaction that ultimately leads to the formation of a single
nucleotide gap in DNA bordered by 5’-and 3’-phosphate groups. The human S3 protein,
although 80 % identical to its Drosophila homolog and shorter by only 2 amino acids,
has only marginal N-glycosylase activity. Its lyase activity only cleaves AP DNA by a β-
elimination reaction, thus further distinguishing itself from the Drosophila S3 protein in
lacking a δ-elimination activity. Using a hidden Markov model analysis based on the
crystal structures of several DNA repair proteins, the enzymatic differences between
Drosophila and human S3 were suggested by the absence of a conserved glutamine
residue in human S3 that usually resides at the cleft of the deduced active site pocket of
DNA glycosylases. Here we show that the replacement of the Drosophila glutamine by
an alanine residue leads to the complete loss of glycosylase activity.  Unexpectedly, the
δ-elimination reaction at AP sites was also abrogated by a change in the Drosophila
glutamine residue. Thus, a single amino-acid change converted the Drosophila activity
into one that is similar to that possessed by the human S3 protein. In support of this
were experiments executed in vivo which showed that human S3 and the Drosophila
site-directed glutamine changes performed poorly when compared to Drosophila wild-
type S3 and its ability to protect a bacterial mutant from the harmful effects of DNA
damaging agents.
3Introduction
Aerobic respiration produces electrophilic oxidants, known as reactive oxygen species
(ROS),which are potentially deleterious to the stability and integrity of DNA. Beyond the
internal cellular production of ROS, the burden of free radical attack on cellular DNA is
increased through the exposure to ionizing radiation (1), cigarette tar and smoke (2),
and the recently discovered presence of stable free-radicals associated with particulate
matter generated by combustion (3).
The impact that free-radicals have on DNA is varied and profound. For example,
single- and double-strand breaks, along with the production of baseless sites in DNA,
are a common result of free radical damage to DNA (4).  Oxidatively-damaged DNA
bases also result from the presence of free-radicals, the most notably being the
formation of 7, 8-dihydro-8-oxoguanine (8-oxoG). This lesion frequently mispairs with
adenine, resulting in G:C→T:A transversion mutations (5) that are exceedingly common
in somatic mutations found in human cancers and, importantly, are abundant in the
tumor suppressor gene p53 (6).
The formation of oxidative damage to DNA is subject to repair by the base
excision repair pathway (BER), which exists as a ubiquitous collection of enzymes that
involves the removal of altered bases, followed by several steps to return the damaged
DNA to its original state.  The liberation of oxidatively-damaged DNA bases is the initial
step in this process, which is catalyzed by an N-glycosylase that cleaves the glycosylic
bond between the sugar and damaged base, resulting in an apurinic/apyrimidinic (AP)
site. For most prokaryotic and eukaryotic enzymes that act on 8-oxoG, the glycosylase
step is followed by a β-elimination lyase reaction that results in a 3’-phosphodiester
cleavage adjacent to the AP site. Mechanistically, the coupling of these two activities
has been thought to be mediated through an ε- amine nucleophile of lysine that attacks
the C-1’ of the damaged nucleotide sugar (7-10). This results in the loss of the base and
the formation of a covalent attachment of the enzyme to the 2’-deoxyribose sugar
moiety of the abasic site, forming an imine (Schiff) base intermediate that can
conveniently be trapped in vitro by sodium borohydride (11). The formation of a Schiff
base is followed by abstraction of the 2’-H and cleavage of the 3’-C-O bond through an
elimination reaction (12-14). In yeast and humans, the identity of the ε-amine group of
4lysine occupies a place in a helix-hairpin-helix-GPD (HhH) domain considered critical for
non-sequence specific binding to DNA (Fig. 1). Also within this active site pocket
domain are an aspartic acid residue that is also essential for catalysis, and a glutamine
residue that resides at the mouth of the active-site pocket, and is believed to be
involved in nucleotide flipping.
For Drosophila S3 (15), Escherichia coli Formamidopyrimidine  DNA glycosylase
(Fpg; mutM) (16), and T4 UV endonuclease (11,17) the β-elimination reaction is
followed by a δ-elimination reaction that results in a one nucleotide gap bordered by a
3’-P, 5’P terminus. The Fpg protein is an example of an enzyme that efficiently removes
8-oxoG through a concerted N-glycosylase/β-δ activity. Conversely, the Drosophila S3
and T4 UV endonuclease V activities appear to carry out a δ-elimination reaction
through a second encounter with an abasic DNA substrate.
In Drosophila, two genes have been identified that are involved in the removal of
8-oxoG (15,18), one being the aforementioned S3 that is involved in both protein
translation and the removal of 8-oxoG from DNA. Studies on the human S3 show that,
even though it is 80% identical to the Drosophila protein and only 2 amino acids shorter,
it catalyzes an entirely different enzymatic reaction. For example, human S3 acts
primarily on heavily UV-irradiated DNA, and it catalyzes only a single β-elimination
reaction at abasic sites residing in DNA (19). The human S3 protein, unlike Drosophila
S3, is extremely inefficient in removing 8-oxoG from oxidatively damaged DNA.
Based on previous studies, S3 appeared to be an orphan among other
eukaryotic 8-oxoG DNA glycosylases (OGGs). However, hidden Markov model-based
analysis suggested structural similarity between the S3 sequence family and, amongst
others, the E. coli repair proteins endonulease III (7,20), MutY (21)and AlkA 3-
methyladenine DNA glycosylase (22,23). Both Drosophila and human S3 possess
conserved amino acids noted above and known to be important for substrate binding
and/or catalysis (Fig. 1).  One obvious difference between the human and Drosophila
S3 protein revealed by this analysis, however, was a glutamine residue (Fig. 2) that
rests at the cleft of the deduced active site pocket (Fig.1), and is considered important
for the “flipping out” of the modified base (24).  We reasoned that the absence in human
S3 of this glutamine residue, and its marginal N-glycosylase activity for the removal of
58-oxoG, might be linked to one another, and therefore offered an excellent model for
testing the importance of this amino acid in performing the N-glycosylase step in base
excision repair. We therefore changed, by site-directed mutagenesis, the glutamine
residue for Drosophila S3. As predicted from our Hidden Markov analysis, a change in
glutamine results in the loss of N-glycosylase acitivity.
Experimental Procedures
Materials. Oligonucleotides containing 8-oxoguanine and uracil were purchased from
Operon Technologies and Midland Certified Reagent Co. respectively. The
QuickChange Site-Directed Mutagenesis Kit was from Stratagene (La Jolla, CA) and the
pGEX3X vector from Pharmacia. Glutathione-agarose and Sodium Borohydride were
purchased from Sigma, aprotinin and leupeptin from Boehringer Mannheim and IPTG
from Gibco BRL. DNA damaging agents MMS and Hydrogen peroxide were from Fluka
and Mallinckrodt respectively. E. coli Uracil DNA glycosylase was purchased from
Epicentre (Madison, WI).
Site-directed mutagenesis. The Drosophila ribosomal protein S3 gene was mutated at
Q59 to alanine (A), and Q59 to asparagine (N) using QuikChange Site-Directed
Mutagenesis Kit following the protocol provided by the manufacturer. The mutagenic
primer sets used for Q59A and Q59N were 5'-
GGCCACCAAGACCCAGGAGGTGCTGGGCGAGAA GG -3' and 5'-
CCTTCTCGCCCAGCACCGCCTGGGTCTTGGTGGCC -3'; 5'-
GGCCACCAAGACCCAGANCGTGCTGGGCGAGAAGG -3' and 5'-
CCTTCTCGCCCAGCACGTTCTGGGTCTTGGTGGCC -3' respectively. The S3 gene in
pGEX3 was used as the template. The colonies containing plasmids with desired
mutations were picked and the mutations were confirmed by DNA sequencing.
Bacterial strains for overexpression or complementation.  AB1157 and its
derivative RPC501 nfo-1::kan∆(xth-pncA) 90 (25) were used in the studies described
here and elsewhere (15) for the characterization of S3.
6Overexpression of GST fusion constructs and purification.  Overnight bacterial
cultures of RPC501 transformed with Drosophila GST-S3, human GST-S3, and
Drosophila mutants GST-S3Q59A and GST-S3Q59N were diluted in pre-warmed
LB+ampicilin media to an OD595=0.1 and grown at 37
oC until cultures reached an
OD595=0.5, then isopropyl-1-thio-β-D-galactopyranoside (IPTG) was added to a final
concentration of 0.1 mM, and growth continued for 3 hours at 27oC. Bacteria were
pelleted by centrifugation and resuspended in phosphate-buffered saline (PBS)
containing 10 µg/ml aprotinin and 10 µg/ml leupeptin. Bacteria were sonicated three
times at 15 sec intervals with constant pulse and cellular debris removed by
centrifugation. The soluble supernatant was then applied to a glutathione-agarose
affinity column, washed with 10 column volumes of PBS, and the fusion construct eluted
(1 ml fractions) with 10 mM reduced glutathione in 50 mM Tris-HCl, pH 7.5. This
resulted in a homogeneous preparation of fusion construct as judged by SDS-PAGE
and Coomassie staining.
Activity on 8-oxoguanine or abasic site containing DNA.  A 37 bp 5’ 32P end-labeled
duplex DNA fragment [5’-CTT GGA CTG GAT GTC GGC ACX AGC GGA TAC AGG
AGC A-3’ where X=8-oxoguanine (8-oxoG-37mer) or uracil at nucleotide position 21
(labeled strand) was used as a substrate either directly, or treated (20 pmol) with E.coli
uracil DNA glycosylase (2 units) to form an apyrimidinic (AP) site in place of the uracil
(26). Following phenol/chloroform extraction, the AP site-containing oligonucleotide (AP-
37mer) was precipitated with cold ethanol.
Reaction mixtures (10 µl) contained ~1 pmol of 5’ end-labeled 37 mer; in
addition, reactions for GST-S3 contained 30 mM HEPES, pH 7.4, 50 mM KCl, 1 µg/ml
bovine serum albumin (BSA), 0.05% TritonX-100, 1 mM DTT and 0.5 mM EDTA. The
DNA reaction products were separated on a 16% polyacrylamide gel containing 7M
urea. Dried gels were subjected to autoradiography for visualization and densitometric
analysis (ChemiImagerTM 4000, Alpha Innotech Corporation).
7Complementation of RPC501.  Overnight cultures of AB1157, RPC501, and RPC501
transformed with Drosophila GST-S3, human GST-S3, and Drosophila mutants GST-
S3Q59A and GST-S3Q59N were diluted to an OD595=0.1, and grown at 37
oC to an
OD595=0.5, at which time IPTG (0.1 mM) was added, and growth allowed to continue for
an additional 3 hours at 27oC. The cultures were normalized to an OD595=1 and serial
dilutions were applied as spots (20 µl) to untreated, MMS and H2O2 treated LB agar
plates.
Formation of Covalent Complexes in the presence of NaBH4.  The fusion proteins
(10 pmol) were combined with NaBH4 (30 mM) and immediately transferred to reaction
mixtures containing 20 pmol of 8-oxoG or AP-37 mer, 30 mM HEPES (pH 7.4), 50 mM
KCl and Triton X-100. Reaction mixtures were incubated at 37oC for 90 min. Incubations
were terminated with the addition of DNA loading dye and samples were loaded on a
10% non-denaturing gel. After electrophoresis, gels were dried under vacuum, and
exposed to autoradiography.
Hidden Markov Modeling.  An iterative procedure for hidden Markov model (HMM)
based analysis of protein sequence families was employed (27). The training set for the
domain OGG HMM consisted of bacterial, archaeal, organellar, and eukaryotic S3’s
together with bacterial  endonuclease III, mutY  and 3-methyladenine DNA glycosylase.
Model training and analysis was performed using SAM suite of programs (see
http://www.cse.ucsc.edu/research/compbio/sam.html and references therein). Figures
for the HMM- generated alignment and ribbon diagram were generated using
ALSCRIPT (28).
8Results
Gln59 →Ala abolishes Drosophila S3 8-oxoG DNA glycosylase activity
In Drosophila, the structural equivalent of E. coli endonuclease III Q41 is gln Q59. To
examine the possible role of gln59 (Q) in the removal of 8-oxoG, we mutated the
residue to ala (A) or asn (N).  The site-directed Drosophila mutants were subsequently
placed in pGEX3X for over-expression and purification in a bacterial strain defective for
AP endonuclease activity (RPC501) (25). The final purification product resulted in
apparently homogenous GST-fusion construct protein preparations (as judged by
Coomassie staining) that had molecular weights identical to that for the wild-type
Drosophila GST-S3 protein (not shown). Tests for 8-oxoG activity were then performed
on a 5’end-labled oligonucleotide containing a single 8-oxoG residue at position 21 (15).
Results show that a change from a gln residue to an ala amino acid completely
abolished N-glycosylase activity (Fig. 3A, lanes 5-7 as compared to lanes 9-11,
respectively). A more conservative substitution with an asn residue (lanes 1-3) also
failed to show activity, except at higher protein concentrations. Notably, these site-
directed changes resemble that possessed by wild-type human S3 (Fig. 3B, lanes 5-7),
in which little if any activity is observed on 8-oxoG residues.
Gln59→Ala converts the Drosophila β-δ elimination reaction at abasic sites to a
human S3-like β-elimination
We next tested what effect the change at gln59 had on the ability of Drosophila S3 to
act on an abasic site existing in a 5’end-labled oligonucleotide. Surprisingly, the gln to
ala change resulted in the Drosophila protein catalyzing a single β-elimination reaction
(Fig. 4A, lanes 9-11). This is in contrast to the wild-type Drosophila S3 activity that
carries out a β-δ elimination reaction (lanes 5-7), but similar to that observed for the
human S3 (Fig. 4B, lanes 5-6) which, like the Drosophila gln→ala change, catalyzes a
single β-elimination reaction.  When the Drosophila gln residue was changed to an asn
residue (Fig 4A, lanes 1-3), activity appeared on the abasic substrate that was greater
than that observed for the change to ala, but nevertheless appeared to lack δ-
elimination activity under the enzymatic conditions employed. Multiple bands were
9however observed using the gln to asn change. When reaction conditions were chosen
in which there was an excess amount of protein (2 pmol), these multiple products
appeared to be entirely driven into a δ-elimination product (Fig. 5A & B, lane 4). Excess
amounts of dS3Q59A, on the other hand, still failed to act on 8-oxoG (Fig. 5A, lane 3),
and generated but a single β-elimination product when acting on the abasic-containing
DNA substrate (Fig 5B, lane 3). It should be noted that the β-elimination product
generated by dS3Q59A was susceptible to δ-cleavage by wild-type Drosophila GST-S3
(not shown), suggesting that absence of this activity in the mutant was not due to it
somehow masking the site from cleavage.
Sodium borohydride mediated trapping of human S3 and Drosophila S3, and
mutants, on 8-oxoG and abasic DNA substrates
A characteristic of virtually all N-glycosylase/AP lyases is that they form an imine
intermediate that can be trapped by sodium borohydride (29).  Using this approach, we
tested whether the lack of N-glycosylase activity exhibited by the gln to ala change
could be traced to an inability of the mutant to bind to pre-existing 8-oxoG or AP sites in
synthetic oligonucleotides. As expected, an electromobility shift assay (EMSA) showed
that the Drosophila S3 protein containing a gln to ala change failed to bind the 8-oxoG
DNA substrate (Fig. 6A, lane 4). It also lacked DNA binding activity for an
oligonucleotide containing an abasic site (Fig. 6B, lane 3). Surprisingly, the more
conservative change to an asn residue resulted in the retention of significant DNA
binding activity to both DNA substrates (Fig 6A, lane 5 and Fig. 6B, lane 4), even
though its catalytic activity towards these DNA substrates is severely compromised
(Figs. 3 and 4). Notably, human S3 was found to efficiently bind a substrate containing
8-oxoG (Fig.6, lane 3), although it lacks the catalytic activity to liberate this base from
DNA.
Does Drosophila S3, its site-directed mutants, and human S3 protect cells from
DNA damaging agents?
An important test for substantiating our in vitro observations was whether they could be
reproduced in an in vivo setting where the individual mutants were challenged to rescue
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bacterial cells from known DNA damaging agents. We utilized a bacterial strain,
RPC501, that is severely compromised in its ability to repair DNA damage produced by
exposure to MMS and hydrogen peroxide (15), which predominantly produce abasic
and oxidatively-damaged sites in DNA, respectively. Wild-type AB1157cells, and
RPC501 cells alone, or RPC501 containing genes shown in Figure 7, were grown to
mid-log phase, at which time IPTG was introduced. After 3 hrs, the cells were
normalized, and then serially diluted onto plates containing MMS (2 mM) or hydrogen
peroxide (0.25 mM). Exposure to MMS showed that RPC501 harboring human S3 was
extremely sensitive to the effects of this DNA damaging agent. Both the gln→ala and
gln→asn mutants of Drosophila S3 also showed sensitivity to MMS when compared to
RPC501 containing the wild-type S3 gene. Perhaps most revealing were the effects that
hydrogen peroxide had on RPC501 harboring the genes depicted in Figure 7, in which
the gln→ala change was slightly less protective than the gln→ asn mutant, which
supports our in vitro observations that the asparagine change is not as deleterious as a
change to alanine. The human S3 appears to be the least capable of protecting cells
from the DNA damaging effects of both MMS and hydrogen peroxide.
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Discussion
The Drosophila S3 gene and its encoded protein was first characterized by our group
because of its highly unusual behavior in human cells. For example, in examining the
presence of AP endonucleases in human cells, Stuart Linn and his laboratory found two
species (30) that could be resolved by separation on phosphocellulose chromatography,
one of which was retained, and subsequently determined to be not only the major AP
endonuclease in human cells, but as well a protein later found for controlling the redox
status of a number of important transcription factors such as Fos and Jun (31).  The
other AP endonuclease characterized by the Linn group flowed through
phosphocellulose, and was subsequently found to be lacking in cell lines of xeroderma
pigmentosum (XP) group-D fibroblasts (32). This protein was later purified to
homogeneity, and found to be ribosomal protein S3 (19).
While the human S3 gene is not defective in XP-D, its expression nevertheless
seems to have a curious relationship with other human diseases. For example, it is
overexpressed in human colorectal cancers (33). And in attempts to clone genes
defective for Fanconi’s anemia and its sensitivity to MMC, the S3 gene was commonly
found to complement the MMC-sensitivity.
The biochemical characterization of human S3 showed that it acted on AP sites,
and on DNA that was heavily exposed to UV-irradiation, by it creating a phosphodiester
break between adjacent thymine residues in a pyrimidine dimer configuration (19).
Drosophila S3 has been found to be a much more versatile enzyme than its
human counterpart. For example, it has vigorous N-glycosylase activity for the removal
of 8-oxoG residues in DNA that human S3 lacks (15,34). It also has a novel dRPase
activity (35) that can remove 5’-AP sites similar to that found for E. coli  Fpg (36) and
human β-DNA polymerase (37). Notably, Drosophila S3 has been shown to also
hydrolytically catalyze the removal of a 3’-AP site (35), suggesting for the first time that
an AP lyase can be an efficient catalyst for the priming of a single nucleotide insertion
into a site generated by a DNA repair protein.
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Although both human and Drosophila S3 exhibit DNA repair activities, neither
had any obvious sequence similarity to eukaryotic and bacterial genes known to be
involved in base excision repair. However, hidden Markov model-based analysis
indicated similarity between the S3 family and other proteins possessing an OGG
domain, most notably E. coli endonuclease III, MutY, and 3-methyladenine DNA
glycosylase.
Especially relevant to our studies was the information available through the
generation of crystal structures of the aforementioned E. coli DNA repair proteins that
aided in identifying those amino acids suspected to be involved in the N-glycosylase
step. Recall that human S3 lacks the ability to remove 8-oxoG, whereas Drosophila S3
possesses the exceptional ability to remove this lesion, and at catalytic rates
comparable to other eukaryotic and prokaryotic OGGs (15). Examination of an S3/OGG
multiple sequence alignment in the context of known OGG domain structures pinpointed
one possible reason for this difference, which was a glutamine residue proposed from
other studies to be important for the “flipping out” of a modified or nonconventional base
in DNA (24), that was preserved in Drosophila S3, but modified to asparigine in human
S3. This difference therefore gave us a unique opportunity to test the importance of a
single amino acid for the glycolytic removal of a modified base, using as a comparison
an enzyme that is highly homologous, but nevertheless incapable of efficiently carrying
out this step in base excision repair.
What can clearly be suggested from our studies is that a glutamine residue in
Drosophila S3, which presumably rests at the mouth of the active site pocket as
predicted from the structure of other DNA repair proteins, is involved in the removal of
8-oxoG. While others have identified a lysine residue as participating in this important
function (8,9), those studies lacked the ability to compare highly homologous proteins in
different organisms in which one lacked the N-glycosylase step. Indeed, drawing
conclusions from a single amino acid change can lead to erroneous interpretations
without a model system such as the one we have been able to exploit.
The helix-hairpin-helix-GPD motif has been concluded to be a trademark of a
“superfamily” of DNA glycosylases (8). Crystallographic studies suggest that the
interaction of the HhH-GPD domain with DNA is mediated by amino acids located in the
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strongly conserved loop (L-P-G-V) and at the N-terminal end of the second helix.
Although the sequence of the equivalent Drosophila loop differs quite considerably (I-M-
E-S), the protein is clearly able to remove 8-oxoG residues in DNA, as well as liberate
5’-and 3’-modified termini at abasic sites in DNA (35).
Unexpectedly, when the N-glycosylase activity of Drosophila S3 was abrogated
with a gln→ala   change, a corresponding loss in the δ-elimination reaction was
observed, thus creating an enzyme that behaves identical to that seen for the human S3
protein. This would imply that the same amino acid could be involved in both the
liberation of a nonconventional base in DNA, and in the δ-cleavage of the
phosphodiester bond 5’ and adjacent to an abasic site.
Our in vitro results were supported by experiments executed in vivo that showed
that a change in gln converted the Drosophila S3 protein product into one that poorly
protected RPC501 from the toxic effects of MMS and H2O2. The amino acid changes to
ala and asn more closely resembled the protective ability conveyed by human S3, which
at the very least was no better than RPC501 on its own. Experiments comparing
Drosophila S3 and human S3 in rescuing the MMC- sensitivity of Fanconi’s anemia
offers another example in which the expression of Drosophila S3 far exceeds that
provided by human S3 (38). The power of S3 to efficiently protect cells from a variety of
different DNA lesions in vivo may lie in its ability to hydrolytically liberate a 3’- abasic
site, and thereby result in a one nucleotide gap in DNA that would be susceptible to
filling by β-DNA polymerase.
We, and others, have concluded that mechanistically the δ-elimination reaction
may involve a second encounter with the remaining abasic site after a concerted N-
glycosylase/AP lyase activity generates an AP site with a phosphodiester break 3’ to the
abasics site (11,15). Our studies tend to point to the involvement of a gln residue for
both the N-glycosylase and δ-elimination activities possessed by Drosophila S3.
However, our results do not rule out the participation of other active-site amino acids
previously shown to be critical for the base excision repair of 8-oxoG.  Clearly,
additional studies are warranted to determine the identity of those amino acids within
the active site pocket that might also be involved in the N-glycosylase/AP lyase steps of
14
base excision repair, and whether the second encounter hypothesis is indeed valid
upon completion of those studies.
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Figure Legends
Figure 1. Ribbon diagram of E. coli endonuclease III (RCSB code 2ABK). The helix-
hairpin-helix domain is shown in red. The side chains of residues important for catalysis
(D138 and K120) and the glutamine examined in this work (Q41) are depicted.
Figure 2. Multiple sequence alignment of Drosophila S3 (Swiss-Prot code
RS3_DROME), human S3 (RS3_HUMAN) and E. coli  endonuclease III
(END3_ECOLI). Residues conserved in all three structures are in cyan. The secondary
structure elements for END_3ECOLI) are based on the crystal structure (2ABK) are
colored-coded usinf the scheme in Figure 1.
Figure 3. Activity on 8oxoguanine containing DNA for different amounts of GST-dS3,
GST-dS3Q59A, GST-dS3Q59N and GST-hS3. Reactions contained 1 pmol of 8oxoG-
37mer incubated with enzyme for 30 min at 37oC. (A) Lanes 1-3, incubations with 0.1,
0.2, and 0.4 pmol of GST-dS3Q59N respectively; lanes 5-7, incubations with 0.1, 0.2,
and 0.4 pmol of GST-dS3, respectively and lanes 9-11, incubations with 0.1, 0.2, and
0.4 pmol of GST-dS3Q59A, respectively. (B) Lanes 2-4, incubations with 0.1, 0.2, and
0.4 pmol of purified GST-dS3 respectively; and lanes 5-7, incubations with 0.1, 0.2, and
0.4 pmol of GST-hS3 respectively. The results presented are representative of 4
independent trials.
Figure 4. Activities of GST-dS3, GST-dS3Q59A, GST-dS3Q59N and GST-hS3 on
abasic site containing DNA. The DNA cleavage products generated from the AP-37mer
were separated on a 16% polyacrylamide DNA sequencing gel and analyzed by
autoradiography. (A) Incubations with GST-dS3Q59N (lanes 1-3); with GST-dS3 (lanes
5-7); and with GST-dS3Q59A (lanes 9-11) contained total protein amounts of 0.1 pmol
(lanes 1,5, and 9), 0.2 pmol (lanes 2, 6, and 10) and 0.4 pmol (lanes 3,7, and 11); lane
4, AP-37mer alone and lane 8, hot piperdine (HA) treatment of AP-37mer to generate a
19
β, δ elimination product. (B) Incubations with 0.1, 0.2, and 0.4 pmol of GST-dS3 (lanes
2-4) and incubations with 0.1 and 0.2 pmol of GST-hS3 (lanes 5-6). The electrophoretic
mobilities of the DNA cleavage products corresponding to β and δ elimination reactions
are indicated. The results presented are representative of 4 independent trials.
Figure 5. Activity of saturating amounts of GST-dS3, GST-dS3Q59A, GST-dS3Q59N
and GST-hS3 on 8-oxoG containing DNA and AP-site containing DNA. (A) 1 pmol
8oxoG-37mer was incubated with 100 ng of GST-dS3 (lane1), GST-hS3 (lane2), GST-
dS3Q59A (lane3), and GST-dS3Q59N (lane 4). (B) 1 pmol abasic site containing DNA
was incubated with 100 ng of GST-dS3 (lane 1), GST-hS3 (lane 2), GST-dS3Q59A
(lane 3), and GST-dS3Q59N (lane 4). The results presented are representative of 4
independent trials.
Figure 6. NaBH4-mediated trapping of GST-dS3, GST-hS3, GST-dS3Q59A, GST-
dS3Q59N and 8oxoG-37mer (A) and AP-37mer (B), respectively. Individual reaction
mixtures (40 µl) contained 8-oxoG (20 pmol) or AP-37mer (20 pmol) and purified fusion
proteins GST-dS3, GST-hS3, GST-dS3Q59A, GST-dS3Q59N (10 pmol). Reaction
samples were applied to a 10% non-denaturing gel, electrophoresed, vacuum dried and
subjected to autoradiography. Control reaction (panel (A) lane 1) was incubated in the
absence of NaBH4. The results presented are representative of 3 independent trials.
Figure 7. Survival of wild-type AB1157 and RPC501 exposed to MMS and H2O2. The
plates contained 0, and 2 mM MMS; and 0, and 0.25 mM H2O2. Serial dilutions of
AB1157 and RPC501 transformed with GST-dS3, GST-hS3, GST-dS3Q59A, and GST-
dS3Q59N were plated as spots (20 µl) and the plates incubated at 37oC for 2-3 days.
The results presented are representative of 3 independent trials.
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